Stefan Groha
Stefan Groha
Dana Farber Cancer Institute, Harvard Medical School, Broad Institute of MIT and Harvard
Verified email at - Homepage
Cited by
Cited by
Prethermalization and thermalization in models with weak integrability breaking
B Bertini, FHL Essler, S Groha, NJ Robinson
Physical review letters 115 (18), 180601, 2015
Thermalization and light cones in a model with weak integrability breaking
B Bertini, FHL Essler, S Groha, NJ Robinson
Physical Review B 94 (24), 245117, 2016
Full counting statistics in the transverse field Ising chain
S Groha, F Essler, P Calabrese
SciPost Physics 4 (6), 043, 2018
Full counting statistics in the spin-1/2 Heisenberg XXZ chain
M Collura, FHL Essler, S Groha
Journal of Physics A: Mathematical and Theoretical 50 (41), 414002, 2017
Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non–Small Cell Lung CancerThyroid irAEs: Genetic Risk and PD-1 Blockade …
J Luo, VL Martucci, Z Quandt, S Groha, MH Murray, CM Lovly, H Rizvi, ...
Clinical Cancer Research 27 (18), 5131-5140, 2021
HLA-A* 03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study
V Naranbhai, M Viard, M Dean, S Groha, DA Braun, C Labaki, SA Shukla, ...
The Lancet Oncology 23 (1), 172-184, 2022
A general framework for survival analysis and multi-state modelling
S Groha, SM Schmon, A Gusev
arXiv preprint arXiv:2006.04893, 2020
Spinon decay in the spin-1/2 Heisenberg chain with weak next nearest neighbour exchange
S Groha, FHL Essler
Journal of Physics A: Mathematical and Theoretical 50 (33), 334002, 2017
Trans-ethnic variation in germline variants of patients with renal cell carcinoma
S Abou Alaiwi, AH Nassar, E Adib, SM Groha, EW Akl, BA McGregor, ...
Cell Reports 34 (13), 108926, 2021
Constructing germline research cohorts from the discarded reads of clinical tumor sequences
A Gusev, S Groha, K Taraszka, YR Semenov, N Zaitlen
Genome medicine 13 (1), 1-14, 2021
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation
SC Baca, C Singler, S Zacharia, JH Seo, T Morova, F Hach, Y Ding, ...
BioRxiv, 2021
Clinical Inflection Point Detection on the Basis of EHR Data to Identify Clinical Trial–Ready Patients With Cancer
KL Kehl, S Groha, EM Lepisto, H Elmarakeby, J Lindsay, A Gusev, ...
JCO Clinical Cancer Informatics 5, 622-630, 2021
Seeing beyond the target: leveraging off-target reads in targeted clinical tumor sequencing to identify prognostic biomarkers
S Mangul, JJ Brito, S Groha, N Zaitlen, A Gusev
bioRxiv, 2021
Topological Data Analysis of copy number alterations in cancer
S Groha, C Weis, A Gusev, B Rieck
arXiv preprint arXiv:2011.11070, 2020
Variation in targetable genomic alterations in non-small cell lung cancer by genetic ancestry, sex, smoking history, and histology
E Adib, AH Nassar, S Abou Alaiwi, S Groha, EW Akl, LM Sholl, ...
Genome medicine 14 (1), 1-10, 2022
SurvLatent ODE: A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Deep Vein Thrombosis (DVT) prediction
I Moon, S Groha, A Gusev
arXiv preprint arXiv:2204.09633, 2022
Genetic variation at IL7 provides mechanistic insights into toxicity to immune checkpoint blockade
B Fairfax, C Taylor, R Watson, O Tong, W Ye, I Nassiri, J Gilchrist, ...
Germline variants associated with immunotherapy-related adverse events
S Groha, S Abou Alaiwi, W Xu, V Naranbhai, AH Nassar, Z Bakouny, ...
medRxiv, 2022
Genetic ancestry and clinical outcomes to immune checkpoint inhibitors among seven common cancers.
A Nassar, E Adib, S Abou Alaiwi, E Akl, T El Zarif, PV Nuzzo, ...
Journal of Clinical Oncology 39 (15_suppl), 10536-10536, 2021
Automated identification of immune related adverse events in oncology patients using machine learning.
W Xu, A Gusev, S Groha, OE Rahma, D Schrag, TK Choueiri, KL Kehl
Journal of Clinical Oncology 39 (15_suppl), 1551-1551, 2021
The system can't perform the operation now. Try again later.
Articles 1–20